Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivien Hsu

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Modern Rheumatology|July 20, 2017
Are there risk factors for scleroderma-related calcinosis?Sneha Pai, Vivien Hsu
Physical Medicine and Rehabilitation Clinics of North America|April 10, 2025
Rheumatologic Issues in Women and RehabilitationSeema Malkana, Jaclyn Joki, Vivien Hsu
Clinical Rheumatology|July 3, 2015
Use of dual-energy computed tomography for the evaluation of calcinosis in patients with systemic sclerosisVivien Hsu, Mark Bramwit, Naomi Schlesinger
Current Opinion in Rheumatology|August 27, 2019
Calcinosis in scleroderma made crystal clearVivien Hsu, John Varga, Naomi Schlesinger
Journal of Clinical Neuromuscular Disease|May 26, 2018
Case of Anti-Single Recognition Particle-Mediated Necrotizing Myopathy After Influenza VaccinationMansoureh Mamarabadi, Ada Baisre, Megan Leitch, et al.
World Journal of Gastrointestinal Surgery|July 5, 2023
Predictors for success of non-operative management of adhesive small bowel obstructionZi Qin Ng, Vivien Hsu, William Wei Han Tee, et al.
Arthritis and Rheumatism|October 2, 2007
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrumentDinesh Khanna, Ron D Hays, Grace S Park, et al.
Heart, Lung & Circulation|December 15, 2005
Ethyl pyruvate enhances ATP levels, reduces oxidative stress and preserves cardiac function in a rat model of off-pump coronary bypassMatthew D Taylor, Todd J Grand, Jeffrey E Cohen, et al.
Arthritis Research & Therapy|February 25, 2014
Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label studyAvram Goldberg, Thomas Geppert, Elena Schiopu, et al.
Arthritis Research & Therapy|June 9, 2016
Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose studyElena Schiopu, Soumya Chatterjee, Vivien Hsu, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Modern Rheumatology|July 20, 2017
Are there risk factors for scleroderma-related calcinosis?Sneha Pai, Vivien Hsu
Physical Medicine and Rehabilitation Clinics of North America|April 10, 2025
Rheumatologic Issues in Women and RehabilitationSeema Malkana, Jaclyn Joki, Vivien Hsu
Clinical Rheumatology|July 3, 2015
Use of dual-energy computed tomography for the evaluation of calcinosis in patients with systemic sclerosisVivien Hsu, Mark Bramwit, Naomi Schlesinger
Current Opinion in Rheumatology|August 27, 2019
Calcinosis in scleroderma made crystal clearVivien Hsu, John Varga, Naomi Schlesinger
Journal of Clinical Neuromuscular Disease|May 26, 2018
Case of Anti-Single Recognition Particle-Mediated Necrotizing Myopathy After Influenza VaccinationMansoureh Mamarabadi, Ada Baisre, Megan Leitch, et al.
World Journal of Gastrointestinal Surgery|July 5, 2023
Predictors for success of non-operative management of adhesive small bowel obstructionZi Qin Ng, Vivien Hsu, William Wei Han Tee, et al.
Arthritis and Rheumatism|October 2, 2007
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrumentDinesh Khanna, Ron D Hays, Grace S Park, et al.
Heart, Lung & Circulation|December 15, 2005
Ethyl pyruvate enhances ATP levels, reduces oxidative stress and preserves cardiac function in a rat model of off-pump coronary bypassMatthew D Taylor, Todd J Grand, Jeffrey E Cohen, et al.
Arthritis Research & Therapy|February 25, 2014
Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label studyAvram Goldberg, Thomas Geppert, Elena Schiopu, et al.
Arthritis Research & Therapy|June 9, 2016
Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose studyElena Schiopu, Soumya Chatterjee, Vivien Hsu, et al.
Pageof 4